EDAP TMS S.A. - Asset Resilience Ratio
EDAP TMS S.A. (FOCL) has an Asset Resilience Ratio of 3.11% as of December 2014. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See FOCL working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2006–2015)
This chart shows how EDAP TMS S.A.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see FOCL total assets.
Liquid Assets Composition Over Time
This chart breaks down EDAP TMS S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read FOCL total liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.21 Million | 3.11% |
| Total Liquid Assets | $1.21 Million | 3.11% |
Asset Resilience Insights
- Limited Liquidity: EDAP TMS S.A. maintains only 3.11% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
EDAP TMS S.A. Industry Peers by Asset Resilience Ratio
Compare EDAP TMS S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
China National Medicines Corp Ltd
SHG:600511 |
Medical Distribution | 0.04% |
|
China National Accord Medicines Corp Ltd
SHE:200028 |
Medical Distribution | -1.21% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for EDAP TMS S.A. (2006–2015)
The table below shows the annual Asset Resilience Ratio data for EDAP TMS S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2015-12-31 | 2.59% | $1.09 Million | $41.91 Million | -0.52pp |
| 2014-12-31 | 3.11% | $1.21 Million | $38.91 Million | -0.61pp |
| 2013-12-31 | 3.72% | $1.38 Million | $37.03 Million | +0.32pp |
| 2012-12-31 | 3.40% | $1.37 Million | $40.14 Million | -1.47pp |
| 2011-12-31 | 4.88% | $2.04 Million | $41.85 Million | +0.65pp |
| 2010-12-31 | 4.23% | $2.04 Million | $48.21 Million | +1.47pp |
| 2009-12-31 | 2.76% | $1.60 Million | $57.93 Million | +0.15pp |
| 2008-12-31 | 2.61% | $1.59 Million | $60.97 Million | +0.19pp |
| 2007-12-31 | 2.42% | $1.59 Million | $65.80 Million | -0.75pp |
| 2006-12-31 | 3.17% | $1.36 Million | $42.82 Million | -- |
About EDAP TMS S.A.
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more